Mechanisms and funding opportunities in genitourinary cancer clinical research

    Research output: Contribution to journalReview articlepeer-review


    Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.

    Original languageEnglish (US)
    Pages (from-to)318-323
    Number of pages6
    JournalUrologic Oncology: Seminars and Original Investigations
    Issue number5
    StatePublished - May 2019


    • Clinical trials
    • Cooperative Groups
    • Funding
    • NCTN
    • Urologic cancers

    ASJC Scopus subject areas

    • Oncology
    • Urology


    Dive into the research topics of 'Mechanisms and funding opportunities in genitourinary cancer clinical research'. Together they form a unique fingerprint.

    Cite this